Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-12-04
1989-12-19
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
048883468
ABSTRACT:
A treatment method for humans infected with HTLV-III (AIDS) virus, including patients clinically diagnosed as suffering from AIDS, those suffering from AIDS-related complex (ARC) as distinguished from AIDS itself, those exhibiting a positive serum test from AIDS virus coupled with a significant measurable dimunition in immunological function, and those simply showing a positive serological test for the AIDS virus without other symptomatic indications, involves the administration, preferably orally where appropriate, of a small but effective amount in the range corresponding to about 1.0-5.0 mg per day for naltrexone, of an opiate receptor antagonist which at the indicated levels exhibits substantially antagonistic or blocking action exclusively upon Mu opiate receptors. The treatment appears from clinical data to impart substantially increased resistance against further progression of the disease beyond its original stage as well as to achieve significant symptomatic relief and clinical protection against serious further deterioration in condition in a predominant number of the patients treated, and appears further to have the ability to repair significantly existing damage to the patient's immunological system. Best results are obtained when the opiate antagonist is administered during the evening or early morning hours as contrasted with daylight or the working times, thereby enhancing the production by the body of endorphins which occurs optimally during such hours.
REFERENCES:
patent: 3773955 (1973-11-01), Pachter et al.
patent: 4181726 (1980-01-01), Bernstein
patent: 4217353 (1980-08-01), Smith, Jr.
patent: 4267182 (1981-05-01), Holaday
patent: 4434168 (1984-02-01), Holaday
patent: 4464378 (1984-08-01), Haussain
patent: 4546103 (1985-10-01), Huebner
Bihari Bernard
Drury Finvola
Daniel William J.
Goldberg Jerome D.
LandOfFree
Method for the treatment of persons infected with HTLV-III (AIDS does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the treatment of persons infected with HTLV-III (AIDS, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of persons infected with HTLV-III (AIDS will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1903095